课题基金 / 基金详情

Genotechnologic Analysis of Control System of Proliferation and Metastasis by Gangliosides in Melanoma

Genotechnologic Analysis of Control System of Proliferation and Metastasis by Gangliosides in Melanoma
神经节苷脂对黑色素瘤增殖和转移控制系统的基因技术分析
批准号:
10670793
负责人:
SHIMIZU Takahiro
金额:
$0.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

SHIMIZU Takahiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We investigated biological functions of gangliosides in melanoma using cell lines and tissue specimens obtained from the patients. SK-MEL-28 (GD3- and GM3-positive cell line) had higher activity of cell proliferation than its GD3-defecient mutant clone. Metastatic melanoma patients with the new ganglioside expression (GM3-predominant) seemed to survive longer than the ones with increased levels of both GM3 and GD3. GD3 was considered to have pivotal parts in concering tumor progression and prognosis. The GD3-deficient cell line, however, showed increased expression of α2β1 and α3β1 integrin receptors and significantly higher ability to adhere to extracellular matrix proteins including type I and IV collagens and laminin than the parent clone (SK-MEL-28). The treatment with monoclonal antibodies against GDs in SK-MEL-28 inhibited the cell attachment to the matrix proteins. Our findings suggest that gangliosides GM3 (by influencing integrin receptor levels) and GD3 (by interacting directly with matrix proteins) might play different biological roles in the progression of melanoma.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Nakano J: "Lack of Induction of Anti-Gangrioside GM_3 antibody in the Patients with Maignant Melanoma in Japanese"Pigment Cell Research. 11. 213-215 (1998)
Nakano J:“日本恶性黑色素瘤患者缺乏抗神经节苷脂 GM_3 抗体的诱导”色素细胞研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakano J: "Lack of Induction of Anti-Gangrioside GM_3 antibody in the Patients with Malignant Melanoma in Japanese"Pigment Cell Research. 11. 213-215 (1998)
Nakano J:“日本恶性黑色素瘤患者缺乏抗神经节苷脂 GM_3 抗体的诱导”色素细胞研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakano, J., et al: "Lack of Induction of Anti-Gangrioside GMィイD23ィエD2 antibody in the Patients with Malignant Melanoma in Japanese"Pigment Cell Research. 11. 213-215 (1998)
Nakano, J., et al:“日本恶性黑色素瘤患者缺乏抗神经节苷脂 GM-D23-D2 抗体的诱导”Pigment Cell Research 11. 213-215 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
武藤正彦: "ヒトメラノーマの分子疫学"腫瘍マーカー研究会誌(電子ジャーナル). (掲載予定). (2000)
Masahiko Muto:“人类黑色素瘤的分子流行病学”肿瘤标志物研究学会杂志(电子期刊)(2000 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    Basic research for treatment of lower urinary tract dysfunction based on the brain mechanisms for stress-induced frequent urination
    • 批准号:
      20K07827
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      SHIMIZU Takahiro
    • 依托单位:
    Brain mechanisms for stress-induced exacerbation of frequent urination
    • 批准号:
      17K09303
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2017
    • 负责人:
      SHIMIZU Takahiro
    • 依托单位:
    Basic research for exploitation of novel central antihypertensive drugs focusing on regulation of responses to stress
    • 批准号:
      26460909
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2014
    • 负责人:
      SHIMIZU Takahiro
    • 依托单位:
    Construction of a conceptual model representing interpersonal situation in a mental nursing scene:From response to acting out of patients with borderline personality disorder
    • 批准号:
      26861973
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.08万
    • 财政年份:
      2014
    • 负责人:
      SHIMIZU Takahiro
    • 依托单位:
    国内基金
    海外基金
    Ganglioside-CD44信号通路在PEMFs对小鼠缺血心肌血管生成影响中的作用及其机制研究
    • 批准号:
      81572231
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2015
    • 负责人:
      魏全
    • 依托单位: